@inproceedings{inproceedings, title  = {{1533 A DNA plasmid melanoma cancer vaccine, SCIB1, combined with nivolumab + ipilimumab in patients with advanced unresectable melanoma: efficacy and safety results from the open-label phase 2 SCOPE trial}},

 publisher = {{BMJ Publishing Group Ltd}},

 url = {{http://dx.doi.org/10.1136/jitc-2023-sitc2023.1533 }},

 year = {{2023}},

 month = {{10}},

 author = {{Shaw H and Patel P and Payne M and Kumar S and Danson S and Highley M and Barlow C and Miller R and Master F and Durrant L}},

 doi = {{10.1136/jitc-2023-sitc2023.1533}},

 journal = {{Late-Breaking Abstracts}},

 note = {{Accessed on 2024/12/26}}}